1 rich Libsyn https://www.libsyn.com 90 600 In this episode of Bladder Cancer Matters, host Rick Bangs speaks with Dr. Josefa Briceno of AstraZeneca about why bladder cancer care may be at a true turning point. From exploring immunotherapy earlier in the disease journey — even around the time of surgery — to strengthening collaboration between urologists and medical oncologists, the conversation highlights how timing, teamwork, and informed shared decision-making are reshaping care. Dr. Briceno explains what this shift means for patients, why education and self-advocacy are essential, and how partnerships between industry and advocacy organizations like BCAN help ensure innovation reflects real patient needs. It’s a hopeful, forward-looking discussion about where bladder cancer treatment is headed — and why patients should feel empowered to be active participants in their care. Bladder Cancer Matters http://bladdercancer.libsyn.com/website <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/40271685/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/ef9a39/" height="90" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/content/199094095